adalimumab
abbvie
['adalimumab']
#epidemiology posters #acr22 0723. risk of mace &amp; vte in ra exposed to jaki vs adalimumab nationwide cohort study france, 14,632 pts 40 &amp; 28 maces - hrw 1.1 [0.6-1.7] 62 and 24 vtes - hrw 1.3 [0.8-2.1]
occurred in exposed and non-exposed #acrambassador
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books